PSORS1C3 rs6682639: What Your Genotype Means
The genetic variant rs6682639 is a single-nucleotide polymorphism situated within the PSORS1C3 non-coding gene on chromosome 6. This genetic marker lies inside the major histocompatibility complex (MHC) class I region, a locus strongly tied to immune function and skin inflammation. Statistical associations have linked variants in this region to susceptibility to psoriasis and related immune-mediated inflammatory traits.
What each genotype means
Baseline susceptibility profile
You carry two copies of the major G allele for rs6682639 in the PSORS1C3 region. In published association studies, this genotype is considered the baseline profile and is not linked to an increased risk of psoriasis compared to carrying the minor allele. Because PSORS1C3 is situated in the complex HLA region where linkage disequilibrium is high, risk is also influenced by broader ancestral haplotypes.
Carried by approximately 40% to 45% of individuals of European ancestry and is commonly observed worldwide.
Slightly altered susceptibility profile
You carry one copy of the minor A allele and one copy of the major G allele. Large-scale association studies within the PSORS1 locus note modest statistical variations in susceptibility to psoriasis and related inflammatory conditions for carriers of this allele. However, the exact functional impact is still debated due to strong linkage with neighboring HLA genes.
Found in roughly 45% to 50% of people of European ancestry.
Altered susceptibility profile
You carry two copies of the minor A allele at rs6682639. Some genetic research into the PSORS1 locus suggests that this genotype may correlate with altered risk patterns for psoriasis, though findings vary across diverse populations. Because this variant resides near HLA-C in a complex genomic region, evidence for an independent causal effect remains limited.
Present in approximately 10% to 15% of European populations, with frequencies varying significantly across other ancestries.
Genomic Location and the PSORS1 Locus
The single-nucleotide polymorphism rs6682639 resides on chromosome 6 in the human leukocyte antigen (HLA) complex. This genomic stretch contains the PSORS1 locus, widely recognized as the primary genetic region predisposing individuals to plaque psoriasis and autoimmune inflammation. Within this cluster, rs6682639 maps to PSORS1C3 (Psoriasis Susceptibility 1 Candidate 3). Because the MHC region possesses exceptional gene density and extensive linkage disequilibrium, many neighboring markers co-segregate across generations, making fine-mapping complex.
Biology and Function of the PSORS1C3 Gene
Unlike classic protein-coding genes, PSORS1C3 produces long non-coding RNA (lncRNA) molecules rather than enzymatic or structural proteins. Emerging evidence suggests this lncRNA participates in epigenetic and transcriptional regulation, including modulating neighboring factors such as OCT4 (POU5F1) and adjacent HLA transcripts. In epidermal cells and immune pathways, non-coding RNAs in the PSORS1 region help coordinate inflammatory signaling cascades, keratinocyte proliferation, and mucosal barrier homeostasis.
Research Associations and Evidence Strength
Genome-wide and regional association studies demonstrate that polymorphisms within PSORS1C3 statistically correlate with altered susceptibility to chronic plaque psoriasis and shared autoimmune phenotypes. However, clinical evidence specifically designating rs6682639 as an independent, causal driver remains limited. Because this variant tracks closely in haplotypes with HLA-C*06:02 and nearby immune markers, researchers debate whether the observed signal stems directly from PSORS1C3 transcript regulation or strong linkage to adjacent HLA alleles.
Population Distribution and Frequency
Allele frequencies for rs6682639 vary across distinct global ancestries due to the demographic history of human immune gene selection. In European populations, the minor allele maintains a frequency of approximately 0.35, representing a common genomic pattern. Frequencies and underlying haplotype structures differ meaningfully in East Asian, African, and Middle Eastern ancestral cohorts, which can alter the statistical risk associations observed across diverse ethnic backgrounds.
Understanding What Your Results Mean
Carrying risk-associated alleles at rs6682639 does not mean you will inevitably develop psoriasis or an autoimmune skin disorder. Common variants in PSORS1C3 represent modest shifts in statistical susceptibility rather than deterministic genetic defects. Lifestyle factors, environmental triggers like infections, and polygenic background heavily shape health outcomes. Genetic results should never replace medical evaluations, and any changes in health status or medications should always be evaluated by a healthcare professional.
How common is this variant?
The minor allele maintains a frequency of roughly 0.35 in European populations, while ancestral variation across other global cohorts alters both allele prevalence and haplotype co-segregation patterns.
Frequently asked questions
Does having the rs6682639 variant mean I will get psoriasis?
No. Psoriasis is a multifactorial condition influenced by hundreds of genetic variants alongside environmental triggers like infections, stress, and skin trauma. Variant rs6682639 indicates only modest statistical susceptibility within populations, not a direct medical diagnosis.
What is the function of the PSORS1C3 gene?
PSORS1C3 encodes a long non-coding RNA (lncRNA) rather than a protein. Research suggests it plays regulatory roles in gene expression, immune signaling, and epidermal cell development inside the major histocompatibility complex.
Why is the evidence for rs6682639 considered limited?
Because rs6682639 sits in an area of tight linkage disequilibrium with other powerful immune genes, such as HLA-C*06:02, it is difficult to determine whether rs6682639 directly drives inflammation or simply tags a neighboring causal variant.
Can this genetic test determine my response to psoriasis medications?
Current pharmacogenomic guidelines do not use rs6682639 to determine prescribing or dosing for psoriasis medications. Always consult a dermatologist or pharmacist before making any decisions regarding treatment plans.
Sources & further reading
Educational information only, last refreshed 9/9/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs6682639?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29